e-learning
resources
Vienna 2012
Sunday, 02.09.2012
CPAP: beneficial effects on different aspects of health
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC)
B. Benedikstdottir, E.S. Arnardottir, C. Jansson, A. Pack, S. Juliusson, T. Gislason (Reykjavik, Iceland; Uppsala, Sweden; Philadelphia, United States Of America)
Source:
Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Session:
CPAP: beneficial effects on different aspects of health
Session type:
Poster Discussion
Number:
436
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Benedikstdottir, E.S. Arnardottir, C. Jansson, A. Pack, S. Juliusson, T. Gislason (Reykjavik, Iceland; Uppsala, Sweden; Philadelphia, United States Of America). Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC). Eur Respir J 2012; 40: Suppl. 56, 436
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Related content which might interest you:
Nocturnal gastro-esophageal reflux and respiratory symptoms in patients with obstructive sleep apnea, before and after CPAP treatment, compared to the general population – The Icelandic Sleep Apnea Cohort (ISAC) study
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Prevalence and impact of symptoms related to restless legs in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Central apnoeas in children with obstructive sleep apnoea syndrome: Prevalence and effect of upper airway surgery
Source: International Congress 2015 – New findings in sleep-disordered breathing in children
Year: 2015
Obstructive sleep apnea syndrome (OSAS) and asthma in a general Norwegian population
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Weight changes in patients with obstructive sleep apnoea syndrome (OSAS) before and after CPAP
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014
Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Upper airway evaluation by drug-induced sleep endoscopy (DISE) in children with Down syndrome and obstructive sleep apnoea
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021
Comparing coping strategies, accident history and driving simulator (MiniUoLDS) outcome in obstructive sleep apnoea syndrome (OSAS) patients and controls
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Impact of speed and age on an office based advanced driving simulator (MinUoLDS) between obstructive sleep apnoea syndrome (OSAS) patients and controls
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Prevalence of obstructive sleep apnea syndrome in obese children (NANOS study)
Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation
Year: 2012
Vasopressin in patients with obstructive sleep apnoea syndrome – An interventional, case-control study
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Clinical presentation and severity of obstructive sleep apnea hypopnea syndrome in Tunisian women
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept